Biotech · Private company

Glycyx Therapeutics

Track this companyFree. Adds Glycyx Therapeutics to your Dealase workspace and tells you when its record changes.

Clinical trials70 recruiting or active

Pipeline programs8From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline8

TD-1211 IV/Oral Mass Balance StudyPHASE1 · COMPLETED · started Nov 1, 2012ClinicalTrials.gov NCT01702194 · fetched Nov 12, 2026
TD-1211 Single-Dose Study in Elderly and Young Healthy SubjectsPHASE1 · COMPLETED · started Aug 1, 2012ClinicalTrials.gov NCT01655771 · fetched Nov 12, 2026
A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD-1211PHASE1 · COMPLETED · started Apr 1, 2012ClinicalTrials.gov NCT01568411 · fetched Nov 12, 2026
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Assess the Safety and Efficacy of TD-1211 in Subjects With Opioid-Induced ConstipationPHASE2 · COMPLETED · started Nov 1, 2011ClinicalTrials.gov NCT01459926 · fetched Nov 12, 2026
A Study of TD-1211 in Subjects With Opioid-Induced Constipation (OIC)PHASE2 · COMPLETED · started Oct 1, 2011ClinicalTrials.gov NCT01401985 · fetched Nov 12, 2026
A Study to Assess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced ConstipationPHASE2 · COMPLETED · started May 1, 2011ClinicalTrials.gov NCT01333540 · fetched Nov 12, 2026
A Multiple Dose Study of TD-1211 in Healthy Volunteers and Patients With Opioid-Induced ConstipationPHASE1_PHASE2 · COMPLETED · started Jan 1, 2010ClinicalTrials.gov NCT01040637 · fetched Nov 12, 2026